香港股市 已收市

  • 恒指

    17,611.87
    +144.97 (+0.83%)
     

  • 國指

    6,069.84
    +39.07 (+0.65%)
     

  • 上證綜指

    3,107.32
    +5.04 (+0.16%)
     

  • 道指

    33,618.88
    -388.00 (-1.14%)
     

  • 標普 500

    4,273.53
    -63.91 (-1.47%)
     

  • 納指

    13,063.61
    -207.71 (-1.57%)
     

  • Vix指數

    18.19
    -0.75 (-3.96%)
     

  • 富時100

    7,609.66
    -16.06 (-0.21%)
     

  • 紐約期油

    91.75
    +1.36 (+1.50%)
     

  • 金價

    1,911.50
    -8.30 (-0.43%)
     

  • 美元

    7.8205
    -0.0003 (-0.00%)
     

  • 人民幣

    0.9343
    +0.0002 (+0.02%)
     

  • 日圓

    0.0522
    -0.0001 (-0.13%)
     

  • 歐元

    8.2485
    -0.0175 (-0.21%)
     

  • Bitcoin

    26,458.95
    +252.50 (+0.96%)
     

  • CMC Crypto 200

    567.91
    +4.10 (+0.73%)
     
你投資 我找數

Yahoo投資達人大賽

現正接受報名

Why Reata Pharmaceuticals Shares Are Falling Monday?

Vandana Singh
·1 分鐘文章

  • According to various reports, the FDA's neuroscience expert Billy Dunn is leaving the agency after more than 15 years, effective immediately.

  • Dunn presided over the controversial approval of Biogen Inc's (NASDAQ: BIIB) Alzheimer's disease treatment, Aduhelm (aducanumab).

  • Dunn, 53, is retiring from the agency to "explore other opportunities," according to an internal FDA email. Dunn notified agency officials Friday, according to a person with knowledge of the situation.

  • Reata Pharmaceuticals Inc (NASDAQ: RETA) shares are falling in reaction to the news as its marketing application seeking approval for omaveloxolone for Friedreich's ataxia is due on 28 February.

  • The FDA has already postponed the application after the company submitted additional data.

  • Friedreich ataxia is a rare inherited disease that causes progressive damage to your nervous system and movement problems.

  • Nerve fibers in your spinal cord and peripheral nerves degenerate, becoming thinner.

  • Price Action: RETA shares are down 35.7% at $28.61 on the last check Monday.

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Why Reata Pharmaceuticals Shares Are Falling Monday? originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.